Trilipix
Product Images NDC 54868-5986

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Trilipix (NDC 54868-5986). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Trilipix Delayed Release Capsules 135 mg (5986)

Trilipix 135 mg delayed-release capsules label from Physicians Total Care, Inc. The label states it contains 30 capsules of fenofibrate acid delayed release. It includes dosage and storage instructions, caution about federal law prohibiting dispensing without prescription, and identifies the NDC 54868-5986.*

FDA Label Image

Chemical Structure For Fenofibric Acid. (Trilipix Structure)

Chemical structure of the active ingredient in Trilipix by Physicians Total Care, Inc., showing a molecule with chlorine, aromatic rings, and an ester functional group, along with a quaternary ammonium ion with an ethanol substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.